
Biotechnology Product Developer
Thermo Fisher Scientific Inc. announced on January 18 that it has received "Good Manufacturing Practice" (GMP) approval from the Italian Medicines Agency to produce RNA-based products at its Monza, Italy, production site. (Interface)Original link